ArticleBlood advances2022

An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma.

Juan Pablo Alderuccio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.